Related Experiment Video
Updated: May 16, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
[An approach to research on nephritic factor and membranoproliferative glomerulonephritis]
1Tsurumi-Nishiguchi Hospital, Kanagawa, Japan.
Abstract:
Although it has been 45 years since membranoproliferative glomerulonephritis (MPGN) and C3 nephritic factor (3NeF) were first reported, the pathophysiology of MPGN is not fully understood at present. Careful analysis of previous case reports of MPGN has been the key to developing approaches to study the mechanisms of MPGN pathophysiology. In this review, previous studies on MPGN, mainly on its association with C3NeF, are discussed and important issues on MPGN as yet unknown are stated. Complements play important roles in MPGN. Studies on complements, particularly C3NeF, advanced as studies on pathophysiology of MPGN progressed and consequently, complement activation alternative pathways were clarified. Important, although not well-known research subjects on MPGN, include characteristics of several kinds of NeF and type I, III and dense deposit disease (DDD). Detailed reading of case reports often yields new research ideas and study directions of the disease and its treatment. The present review demonstrates that reviewing previous case reports is one approach to further advancing our understanding of the complicated disease of MPGN.
Insights
Membranoproliferative glomerulonephritis (MPGN) pathophysiology remains unclear despite decades of research. Reviewing past case reports offers crucial insights into MPGN mechanisms and potential treatments, especially concerning C3 nephritic factor (C3NeF).
Area of Science:
- Nephrology
- Immunology
- Pathophysiology
Context:
- Membranoproliferative glomerulonephritis (MPGN) and C3 nephritic factor (C3NeF) were first described 45 years ago.
- The precise pathophysiology of MPGN is not yet fully elucidated.
- Case reports have historically been instrumental in advancing MPGN research.
Purpose:
- To review existing studies on MPGN, focusing on its association with C3NeF.
- To highlight unknown aspects of MPGN pathophysiology.
- To emphasize the value of analyzing case reports for new research directions.
Summary:
- Complement system, particularly C3NeF, plays a critical role in MPGN.
- Studies on C3NeF have advanced the understanding of complement alternative pathway activation.
- Key research areas include NeF characteristics and MPGN types like DDD.
Impact:
- Case report analysis provides a viable approach to deepen the understanding of MPGN.
- This review underscores the importance of historical data in uncovering complex disease mechanisms.
- Further research into NeF and specific MPGN subtypes can yield new therapeutic strategies.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

